How pharmacists are storing medicines in soaring temperatures What is being done to ensure hospitals can store medicines safely as heatwaves become more prevalent and what steps are pharmacists taking to maintain medicines integrity in the short term?…
Post-finasteride syndrome: pharmacists must lead the conversation on patient safety We would not accept a tooth-whitening procedure that carried a risk of suicide, persistent sexual dysfunction and irreversible neurological harm. Why is it being accepted with finasteride?…
What the UK’s new clinical trials regime means for pharmacy practice and patient safety Pharmacists will be central to the impact of the new clinical trial regime, which is aimed to streamline regulatory timelines.…
PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…
Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…
‘Stark lack of government response’ on valproate redress, patient safety commissioner says In her annual report for 2025/2026, Henrietta Hughes said the government was “yet to announce a redress scheme or a timeline for providing a substantive response to the recommendations” made in her previous report on patients harmed by sodium valproate.…
GPhC launches campaign on risk of fake online pharmacies following launch of oral semaglutide The General Pharmaceutical Council has created posters and videos to educate patients on how to spot a fake online pharmacy.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Pharmacy regulator warns against promotion of prescription weight-loss medicines A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…
Restarting psychotropics after a treatment break: patient considerations and the pragmatic approach How to support safe, person-centred re-initiation of antidepressants, antipsychotics and mood stabilisers.…
